$PNXP
PINEAPPLE EXPRESS CANNABIS Co Stock $pnxp

$pnxp Overview Financials Valuation SEC Filings Company Website

2025 Q1 Form 10-Q Financial Statement

#000149315225002983 Filed on January 21, 2025

Income Statement

Concept	2025 Q1	2024 Q4
Revenue		$4.332K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit		$4.332K
YoY Change
Gross Profit Margin		100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$5.580K
YoY Change		163.83%
Operating Profit		-$1.248K
YoY Change		-40.99%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		-$1.248K
YoY Change		-100.87%
Income Tax
% Of Pretax Income
Net Earnings		-$1.248K
YoY Change		-100.88%
Net Earnings / Revenue		-28.81%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share		$0.00
COMMON SHARES
Basic Shares Outstanding	19.83M shares	19.83M shares
Diluted Shares Outstanding		19.84M shares

Balance Sheet

Concept	2025 Q1	2024 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$1.000K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$14.20K
Other Receivables
Total Short-Term Assets		$15.20K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment		$1.495K
YoY Change		-23.53%
Goodwill
YoY Change
Intangibles		$3.000M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$1.495K
YoY Change		-23.53%
TOTAL ASSETS
Total Short-Term Assets		$15.20K
Total Long-Term Assets		$1.495K
Total Assets		$3.017M
YoY Change		180.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$20.48K
YoY Change		30.73%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$2.988M
YoY Change		18970.76%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$2.988M
Total Long-Term Liabilities
Total Liabilities		$2.988M
YoY Change		18970.76%
SHAREHOLDERS EQUITY
Retained Earnings		-$924.1K
YoY Change		-362.79%
Common Stock		$19.83K
YoY Change		-2.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$28.50K
YoY Change
Total Liabilities & Shareholders Equity		$3.017M
YoY Change		180.37%

Cashflow Statement

Concept	2025 Q1	2024 Q4
OPERATING ACTIVITIES
Net Income		-$1.248K
YoY Change		-100.88%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
	dei	Entity Central Index Key EntityCentralIndexKey	0001710495
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2024Q1	PNXP	Other Asset OtherAsset		usd
CY2024Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2024Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	PNXP	Stock Issued During Period Value Cancellation Of Common Stock StockIssuedDuringPeriodValueCancellationOfCommonStock		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect		usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Interest Paid InterestPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	36-4864568
	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2025Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19834550	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2024Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30	usd
CY2024Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14204	usd
CY2024Q4	us-gaap	Assets Current AssetsCurrent	15204	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	30	usd
CY2024Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3000000	usd
CY2024Q4	PNXP	Other Asset OtherAsset	3000000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	17797	usd
CY2024Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2967714	usd
CY2024Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2988198	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	17797	usd
CY2024Q4	us-gaap	Liabilities Liabilities	2988198	usd
CY2024Q1	us-gaap	Liabilities Liabilities	17797	usd
CY2024Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2024Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20344550	shares
CY2024Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20344550	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19004550	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19004550	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19836217	shares
CY2024Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19836217	shares
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20344550	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20344550	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-15927	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	45000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-572	usd
	us-gaap	Net Income Loss NetIncomeLoss	-572	usd
CY2024Q4	us-gaap	Stockholders Equity StockholdersEquity	28501	usd
	us-gaap	Net Income Loss NetIncomeLoss	-572	usd
	us-gaap	Net Income Loss NetIncomeLoss	934669	usd
	us-gaap	Depreciation Depreciation	345	usd
	us-gaap	Depreciation Depreciation	345	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14204	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2668	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	14365	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	985737	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11763	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-36358	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	12144	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	36358	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12144	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36358	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	381	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30	usd
CY2024Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1000	usd
CY2024Q2	PNXP	Management Fee Percentage ManagementFeePercentage	0.10	pure
CY2024Q2	us-gaap	Convertible Debt ConvertibleDebt	5000000	usd
CY2024Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2024Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2029-04-20
CY2024Q3	us-gaap	Convertible Debt ConvertibleDebt	2000000	usd
CY2024Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-924146	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zCejsWguAgli" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zkIO52muXdMi">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PINEAPPLE EXPRESS CANNABIS COMPANY AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f/k/a Minaro Corp.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>October 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2024Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	2966714	usd
CY2024Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2024Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2029-04-20
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2023Q4	us-gaap	Gross Profit GrossProfit		usd
CY2024Q4	us-gaap	Deposits Deposits		usd
CY2024Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Address Address Line1 EntityAddressAddressLine1	12301 Wilshire Blvd Ste 302
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90025
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	245-5703
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1060320	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
	dei	Entity File Number EntityFileNumber	001-41762
	dei	Entity Registrant Name EntityRegistrantName	PINEAPPLE EXPRESS CANNABIS COMPANY
CY2024Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1495	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1840	usd
CY2024Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1495	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1840	usd
CY2024Q4	us-gaap	Assets Assets	3016699	usd
CY2024Q1	us-gaap	Assets Assets	1870	usd
CY2024Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20484	usd
CY2024Q4	us-gaap	Common Stock Value CommonStockValue	19834	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	20745	usd
CY2024Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	932812	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	887902	usd
CY2024Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-924146	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-924574	usd
CY2024Q4	us-gaap	Stockholders Equity StockholdersEquity	28501	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-15927	usd
CY2024Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3016699	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1870	usd
CY2024Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4332	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2024Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2024Q4	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-10-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90025
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16168	usd
CY2024Q4	us-gaap	Gross Profit GrossProfit	4332	usd
	us-gaap	Gross Profit GrossProfit	16168	usd
CY2024Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5580	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2115	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16740	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51068	usd
CY2024Q4	us-gaap	Operating Expenses OperatingExpenses	5580	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	2115	usd
	us-gaap	Operating Expenses OperatingExpenses	16740	usd
	us-gaap	Operating Expenses OperatingExpenses	51068	usd
CY2024Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1248	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2115	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-572	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-51068	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	985737	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	985737	usd
CY2024Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1248	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2115	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-572	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	934669	usd
CY2024Q4	us-gaap	Net Income Loss NetIncomeLoss	-1248	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-2115	usd
	us-gaap	Net Income Loss NetIncomeLoss	-572	usd
	us-gaap	Net Income Loss NetIncomeLoss	934669	usd
CY2024Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19836217	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19836217	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20344550	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20344550	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-544350	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	670001	usd
	us-gaap	Net Income Loss NetIncomeLoss	934669	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-15927	usd
CY2024Q4	us-gaap	Stockholders Equity StockholdersEquity	28501	usd

Files In Submission

Name	View Source	Status
0001493152-25-002983-index-headers.html	Edgar Link	pending
0001493152-25-002983-index.html	Edgar Link	pending
0001493152-25-002983.txt	Edgar Link	pending
0001493152-25-002983-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pnxp-20241031.xsd	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pnxp-20241031_pre.xml	Edgar Link	unprocessable
pnxp-20241031_cal.xml	Edgar Link	unprocessable
pnxp-20241031_def.xml	Edgar Link	unprocessable
pnxp-20241031_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PNXP
PINEAPPLE EXPRESS CANNABIS Co Stock $pnxp

2025 Q1 Form 10-Q Financial Statement

#000149315225002983 Filed on January 21, 2025

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PNXP PINEAPPLE EXPRESS CANNABIS Co Stock $pnxp

2025 Q1 Form 10-Q Financial Statement

#000149315225002983 Filed on January 21, 2025

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PNXP
PINEAPPLE EXPRESS CANNABIS Co Stock $pnxp